Endeavour Vision is a growth-stage investor that invests in growth-stage medtech and digital health companies in Europe and the US.
Endeavour Vision is a leading private equity firm investing in growth-stage MedTech and digital health companies. We invest in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018), and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s offices are located in Geneva, Switzerland, and Minneapolis, U.S.